摘要
目的:探讨针灸联合药物治疗周围性面神经麻痹(PFP)患者的效果。方法:选取建瓯市中西医结合医院2019年1月-2021年4月收治的55例PFP患者。按照随机数字表法将其分为对照组(n=27)和观察组(n=28)。对照组予以药物治疗,观察组在对照组基础上予以针灸治疗。比较两组临床疗效,治疗前后免疫功能、炎症因子及面神经功能麻痹程度。结果:治疗后,观察组总有效率(96.43%)高于对照组(70.37%)(P<0.05)。治疗后,观察组免疫球蛋白G(IgG)、免疫球蛋白A(IgA)、免疫球蛋白M(IgM)、超敏C反应蛋白(hs-CRP)、白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)及白细胞介素-6(IL-6)水平均低于对照组(P<0.05)。治疗后,观察组面神经功能麻痹程度优于对照组(P<0.05)。结论:针灸联合药物治疗PFP患者,改善患者免疫功能,降低面神经麻痹程度,进而提高临床疗效。
Objective:To explore the effect of Effect of acupuncture combined with drugs in the treatment of patients with peripheral facial paralysis (PFP).Method:A total of 55 patients with PEP admitted to Jian’ou Hospital of Integrated Traditional Chinese and Western Medicine from January 2019 to April 2021 were selected.According to random number table method,they were divided into control group (n=27) and observation group (n=28).The control group was given drug treatment,and the observation group was given acupuncture treatment on the basis of the control group.The clinical efficacy,immune function,inflammatory factors before and after treatment and facial nerve function paralysis degree were compared between the two groups.Result:After treatment,the total effective rate of observation group (96.43%) was higher than that of control group (70.37%) (P<0.05).After treatment,the levels of immunoglobulin G (IgG),immunoglobulin A (IgA),immunoglobulin M (IgM),high-sensitivity C-reactive protein (hs-CRP) and interleukin-1β (IL-1β),tumor necrosis factor-α(TNF-α),interleukin-6 (IL-6) in the observation group were lower than those in the control group (P<0.05).After treatment,the facial nerve function paralysis degree in the observation group was better than that in the control group (P<0.05).Conclusion:Acupuncture combined with drugs in the treatment of patients with PEP can improve the patients’ immune function and reduce the degree of facial nerve paralysis,and then improve the clinical efficacy.
作者
黄美英
HUANG Meiying(Jian’ou Hospital of Integrated Traditional Chinese and Western Medicine,Jian’ou 353100,China)
出处
《中外医学研究》
2022年第13期119-123,共5页
CHINESE AND FOREIGN MEDICAL RESEARCH